A Trial of E-cigarettes in Current Cigarette Smokers

March 7, 2018 updated by: Medical University of South Carolina

A Trial of E-cigarettes: Natural Uptake, Patterns and Impact of Use

The purpose of this study is to examine cigarette smokers' use of electronic cigarettes (e-cigarettes), and how use of e-cigarettes affects short term smoking behavior.

Study Overview

Detailed Description

Study initiation will commence after the first telephone contact (phone pre-screen), at the baseline visit. Additional lab visits will occur at days 8, 15, and 22 (visits 2-4). At the first study visit, 2/3rds of the participants will be randomly assigned to sample e-cigarettes and 1/3rd will not. Participants in the e-cigarette group will be provided with sufficient product to sample and use as they wish, but with minimal instruction on purpose and level of use (non-use is an outcome). Smokers in the control group will smoke their own brand of cigarettes, as they wish, for the duration of the sampling period. All participants will engage in ecological momentary assessments, which will be completed 3 times daily for 3 weeks. In-person follow-up assessments will be conducted at 1, 2, and 3 months after the final lab visit (Day 22).

Overall, each participant will be contacted 8 times: at the phone pre-screening, the 4 lab visits, and 3 follow-up visits.

Study Type

Interventional

Enrollment (Actual)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • South Carolina
      • Charleston, South Carolina, United States, 29425
        • Medical University of South Carolina

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age 18+
  • current smoker of at least 5 cigarettes per day for at least 1 year
  • at least some concern for health effects of smoking
  • having an easily accessible email address

Exclusion Criteria:

  • past six month use of any e-cigarette
  • lifetime ever purchase of any e-cigarette
  • recent history of cardiovascular distress (heart attack in past year; arrhythmia; uncontrolled hypertension)
  • recent history (past 3 months) of Chronic Obstructive Pulmonary Disease (COPD), cancer (any non-dermatologic), or uncontrolled diabetes mellitus
  • pregnant or breastfeeding
  • any major current psychiatric impairment, including current alcohol/drug abuse/dependence
  • use of non-cigarette tobacco products (e.g., cigarillos) in the last 30 days
  • current use of any smoking cessation medications
  • current enrollment in a smoking cessation treatment study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: cigarette group
This group (1/3 of the sample) will not receive electronic cigarettes to sample and will continue smoking their regular cigarettes as much or as little as they would like.
Experimental: electronic cigarette
This group (2/3 of the sample) will be given electronic cigarettes for a 3-week period, to use as much or as little as they would like.
Other Names:
  • Blu ecigs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Uptake of Electronic Nicotine Delivery Systems (ENDS)
Time Frame: study week 16
% of participants by group used e-cigarettes in week 16
study week 16
Independent Purchase of an ENDs Product
Time Frame: study enrollment to study week 16
% of participants by group who purchased an ENDs product on their own during the study
study enrollment to study week 16
% Quit Attempts
Time Frame: study enrollment to study week 16
% of participants who made any quit attempt during study
study enrollment to study week 16
Point Prevalence Abstinence
Time Frame: week 16
% of participants with CO-verified cigarette abstinence at study week 16
week 16

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matthew J Carpenter, PhD, Medical University of South Carolina

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2014

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

July 1, 2017

Study Registration Dates

First Submitted

October 3, 2014

First Submitted That Met QC Criteria

February 2, 2015

First Posted (Estimate)

February 6, 2015

Study Record Updates

Last Update Posted (Actual)

April 4, 2018

Last Update Submitted That Met QC Criteria

March 7, 2018

Last Verified

November 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00035634
  • 1R21DA037407-01 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking

Clinical Trials on cigarette group

Subscribe